Indefinite Delivery Contract SPE2DB24D2102

The Defense Logistics Agency (DLA) Troop Support Medical awarded a single award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The IDC, valued up to $999,999,999.00, has a period of performance through December 31, 2025. This contract serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense worldwide. Task orders issued under the IDC enable the provision of specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, test kits, and other medical supplies. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation to provide similar medical products and prescription drugs, valued up to $750,000 through May 2024.

The IDC does not utilize any set-aside designations, indicating it is a full and open competition award. As the prime contractor, Amerisourcebergen Drug Corp leverages its extensive experience and capabilities in pharmaceutical distribution and government contracting to meet the DLA's requirements for provisioning a reliable supply of essential medical commodities to military treatment programs and facilities globally. The contract supports the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces, other government agencies, and foreign countries.